Skip to main content
TipRanks
Go Ultimate75% OFF

T2 Biosystems (TTOO) Ratios

2,236 Followers

T2 Biosystems Ratios

TTOO's free cash flow for Q3 2024 was $-6.25M. For the 2024 fiscal year, TTOO's free cash flow was increased by $0.00 and operating cash flow was $-6.25M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 23Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio0.451.923.805.470.31
Quick Ratio0.361.493.465.100.25
Cash Ratio0.281.021.901.710.18
Solvency Ratio-0.78-0.82-0.64-0.62-0.89
Operating Cash Flow Ratio-0.86-5.00-3.33-4.41-0.75
Short-Term Operating Cash Flow Coverage-1.17-37.450.00-37.55-1.06
Net Current Asset Value$ -37.64M$ -54.94M$ -29.05M$ -16.77M$ -43.60M
Leverage Ratios
Debt-to-Assets Ratio1.421.720.960.721.57
Debt-to-Equity Ratio-1.77-1.48-4.526.52-1.32
Debt-to-Capital Ratio2.313.081.280.874.16
Long-Term Debt-to-Capital Ratio0.005.131.370.840.00
Financial Leverage Ratio-1.24-0.86-4.699.06-0.84
Debt Service Coverage Ratio-0.94-7.38-5.41-5.52-0.96
Interest Coverage Ratio-9.30-8.88-5.66-7.51-7.08
Debt to Market Cap2.527.040.580.310.81
Interest Debt Per Share21.011280.342074.752572.455727.17
Net Debt to EBITDA-0.77-0.89-0.88-1.09-0.70
Profitability Margins
Gross Profit Margin-113.58%5.23%26.21%-17.37%-101.12%
EBIT Margin-621.91%-250.70%-155.62%-219.88%-623.17%
EBITDA Margin-609.97%-246.01%-146.58%-202.48%-579.47%
Operating Profit Margin-690.45%-242.30%-153.16%-228.11%-624.57%
Pretax Profit Margin-696.19%-277.98%-175.50%-258.12%-707.93%
Net Profit Margin-696.19%-277.98%-175.50%-258.12%-707.93%
Continuous Operations Profit Margin-696.19%-277.98%-175.50%-258.12%-707.93%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT100.83%114.72%114.59%113.16%113.35%
Return on Assets (ROA)-143.91%-180.29%-81.34%-59.18%-207.14%
Return on Equity (ROE)178.62%155.13%381.62%-536.31%173.52%
Return on Capital Employed (ROCE)232.56%-222.75%-87.97%-59.70%162.25%
Return on Invested Capital (ROIC)-230.51%-200.41%-85.90%-57.78%-406.73%
Return on Tangible Assets-143.91%-180.29%-81.34%-59.18%-207.14%
Earnings Yield-305.52%-856.11%-60.07%-31.11%-110.83%
Efficiency Ratios
Receivables Turnover5.0710.315.473.562.95
Payables Turnover10.0616.317.3110.344.47
Inventory Turnover3.194.865.305.854.66
Fixed Asset Turnover0.791.681.941.220.91
Asset Turnover0.210.650.460.230.29
Working Capital Turnover Ratio-0.661.060.7317.21-0.45
Cash Conversion Cycle150.2788.1185.77129.72120.36
Days of Sales Outstanding72.0635.4066.79102.65123.71
Days of Inventory Outstanding114.4975.0968.9262.3778.37
Days of Payables Outstanding36.2822.3849.9335.3081.72
Operating Cycle186.55110.49135.70165.02202.08
Cash Flow Ratios
Operating Cash Flow Per Share-18.44-992.67-1223.53-1780.89-4984.18
Free Cash Flow Per Share-18.52-999.31-1238.01-1814.02-5067.79
Dividend Paid and CapEx Coverage Ratio-250.71-149.35-84.51-53.75-59.61
Capital Expenditure Coverage Ratio-250.71-149.35-84.51-53.75-59.61
Operating Cash Flow Coverage Ratio-0.97-0.85-0.67-0.76-1.01
Operating Cash Flow to Sales Ratio-6.69-2.27-1.39-2.38-5.44
Free Cash Flow Yield-294.85%-703.74%-47.98%-29.26%-86.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.33-0.12-1.66-3.21-0.90
Price-to-Sales (P/S) Ratio2.280.322.928.306.39
Price-to-Book (P/B) Ratio-0.58-0.18-6.3517.24-1.57
Price-to-Free Cash Flow (P/FCF) Ratio-0.34-0.14-2.08-3.42-1.15
Price-to-Operating Cash Flow Ratio-0.34-0.14-2.11-3.48-1.17
Price-to-Earnings Growth (PEG) Ratio0.000.010.080.04-0.00
Enterprise Value Multiple-1.14-1.02-2.87-5.19-1.80
Enterprise Value50.20M56.13M118.05M190.58M86.98M
EV to EBITDA-1.14-1.02-2.87-5.19-1.80
EV to Sales6.982.524.2110.5110.44
EV to Free Cash Flow-1.04-1.10-3.00-4.33-1.89
EV to Operating Cash Flow-1.04-1.11-3.04-4.41-1.92
Tangible Book Value Per Share-10.74-783.66-406.11359.60-3736.40
Shareholders’ Equity Per Share-10.74-783.66-406.11359.60-3736.40
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share2.76437.33883.10747.14915.83
Net Income Per Share-19.19-1215.67-1549.82-1928.54-6483.46
Tax Burden1.001.001.001.001.00
Interest Burden1.121.111.131.171.14
Research & Development to Revenue1.971.160.780.931.96
SG&A to Revenue0.001.370.000.000.00
Stock-Based Compensation to Revenue0.600.290.250.220.65
Income Quality0.960.820.790.920.77

Currency in USD